Mochida Pharmaceutical Co (TSE:4534) E10: 円215.72 (As of Mar. 2026)


TSE:4534 Mochida Pharmaceutical Co Ltd TSE:4534
71 GF Score
Price 円3,135.00
GF Value 円3,695.27
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co E10?

Mochida Pharmaceutical Co TSE:4534 -0.16% 71 E10 is 円215.72 as of Mar. 2026. GuruFocus rates TSE:4534 with a GF Score™ of 71/100 and a GF Value™ of 円3,695.27 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was 円44.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円215.72 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Mochida Pharmaceutical Co's average E10 Growth Rate was 0.90% per year. During the past 3 years, the average E10 Growth Rate was -0.70% per year. During the past 5 years, the average E10 Growth Rate was -0.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Mochida Pharmaceutical Co was 2.70% per year. The lowest was -0.90% per year. And the median was 0.15% per year.

As of today (2026-06-29), Mochida Pharmaceutical Co's current stock price is 円3135.00. Mochida Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was 円215.72. Mochida Pharmaceutical Co's Shiller PE Ratio of today is 14.53.

During the past 13 years, the highest Shiller PE Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.72. And the median was 16.73.


Mochida Pharmaceutical Co  (TSE:4534) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mochida Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3135.00/215.72
=14.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Mochida Pharmaceutical Co was 27.34. The lowest was 13.72. And the median was 16.73.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mochida Pharmaceutical Co E10 Related Terms


Mochida Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Mochida Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co E10 Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 219.39 220.06 211.25 213.81 215.72

Mochida Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 213.81 211.16 212.64 211.16 215.72

TSE:4534 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mochida Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's Shiller PE Ratio falls into.


TSE:4534
71GF Score
Mochida Pharmaceutical Co Ltd TSE:4534
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mochida Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mochida Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=44.05/112.7000*112.7000
=44.050

Current CPI (Mar. 2026) = 112.7000.

Mochida Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 82.480 98.100 94.755
201609 57.590 98.000 66.229
201612 106.592 98.400 122.083
201703 -31.958 98.100 -36.714
201706 108.770 98.500 124.451
201709 40.395 98.800 46.078
201712 84.315 99.400 95.597
201803 -6.221 99.200 -7.068
201806 147.190 99.200 167.221
201809 27.510 99.900 31.035
201812 73.373 99.700 82.940
201903 -36.044 99.700 -40.744
201906 84.250 99.800 95.140
201909 32.807 100.100 36.937
201912 45.670 100.500 51.214
202003 -45.931 100.300 -51.609
202006 86.890 99.900 98.023
202009 52.740 99.900 59.497
202012 77.560 99.300 88.026
202103 4.703 99.900 5.306
202106 69.350 99.500 78.550
202109 59.120 100.100 66.562
202112 137.820 100.100 155.168
202203 10.354 101.100 11.542
202206 83.980 101.800 92.972
202209 20.593 103.100 22.510
202212 111.850 104.100 121.090
202303 -39.197 104.400 -42.313
202306 46.240 105.200 49.537
202309 32.150 106.200 34.118
202312 45.090 106.800 47.581
202403 2.905 107.200 3.054
202406 43.850 108.200 45.674
202409 35.860 108.900 37.111
202412 78.400 110.700 79.816
202503 2.250 111.100 2.282
202506 53.430 111.700 53.908
202509 55.360 112.000 55.706
202512 70.120 113.000 69.934
202603 44.050 112.700 44.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of 円215.72 mean?
Mochida Pharmaceutical Co (TSE:4534) has a E10 of 円215.72 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mochida Pharmaceutical Co and its competitors.
Is Mochida Pharmaceutical Co's E10 too high?
Mochida Pharmaceutical Co's current E10 is 円215.72. Overall, Mochida Pharmaceutical Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's E10 compare to ZTS and UTHR?
Mochida Pharmaceutical Co's E10 of 円215.72 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mochida Pharmaceutical Co and its competitors. Mochida Pharmaceutical Co's current E10 is 円215.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Mochida Pharmaceutical Co (TSE:4534) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,695.27, compared to a current price of 円3,135.00 — trading 15.2% below its estimated fair value. The current E10 is 円215.72. Mochida Pharmaceutical Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Mochida Pharmaceutical Co (TSE:4534), the current E10 is 円215.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mochida Pharmaceutical Co (TSE:4534) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of 円3,135.00 is trading 15.2% below its estimated GF Value™ of 円3,695.27. GuruFocus considers Mochida Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4534:

  • E10: 円215.72
  • GF Value™: 円3,695.27 vs. price of 円3,135.00 (15.2% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the TSE:4534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mochida Pharmaceutical Co Business Description

Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
71GF Score

Get the complete analysis for TSE:4534

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,135.00
Price
円3,695.27
GF Value